Browse All

Current Filters

CLEAR FILTER x

TITLE

Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment

Author:Alford, Susan   Johannsen, Peter   Bentsen, Marie   Belmont-Rausch, Dylan   Carstensen, Lisbeth   Jeppesen, Rose   Martino, Gabriel   Jimenez Mausbach, Marti   Knudsen, Lotte   

Session Name:P3: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P3.012  

Author Institution:Novo Nordisk, Inc., Plainsboro, NJ  Novo Nordisk, Copenhagen, Denmark  

Masupirdine (A Pure 5-HT6 Receptor Antagonist): Clinical Development Program Targeting Agitation in Alzheimer’s Dementia – Phase-3 Study Updates

Author:Nirogi, Ramakrishna   Jetta, Satish   Goyal, Vinod Kumar   Benade, Vijay   Shinde, Anil   Abraham, Renny   Pandey, Santosh Kumar   Palacharla, Veera Raghava Chowdary   Subramanian, Ramkumar   Mohammed, Abdul Rasheed   Jayarajan, Pradeep   

Session Name:P3: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P3.014  

Author Institution:Suven Life Sciences Ltd, Hyderabad, India